Adagene | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Trial results

12 October 2023

Tempest kicks up a storm as Morpheus strikes again

Tempest Therapeutics confirms an earlier success with its lead project, and this time investors respond.

Subscribe to Adagene